HomeInsightsResults

Torrent Pharmaceuticals Ltd Quarterly Result

Torrent Pharmaceuticals Ltd Quarterly Result

stocks purchased

₹ 2.4 Cr

Volume transacted

stocks purchased

7.4 K

stocks traded

Last Updated time: 29 Oct 9.00 AM

Results Analysis

Revenue

2,831 Cr

stock direction

16 (0.57%)

2,815 Cr

NetProfit

453 Cr

stock direction

4 (-0.88%)

457 Cr

EBIDTA

939 Cr

stock direction

35 (3.87%)

904 Cr

Key Highlights

  • The Market Cap of Torrent Pharmaceuticals Ltd changed from ₹ 33035 crore on March 2019 to ₹ 88030 crore on March 2024 . This represents a CAGR of 17.75% over 6 years. .
  • The Revenue of Torrent Pharmaceuticals Ltd changed from ₹ 2377 crore to ₹ 2873 crore over 10 quarters. This represents a CAGR of 7.88% .
  • The EBITDA of Torrent Pharmaceuticals Ltd changed from ₹ 742 crore to ₹ 923 crore over 10 quarters. This represents a CAGR of 9.12% .
  • The Net Pr of Torrent Pharmaceuticals Ltd changed from ₹ 354 crore to ₹ 453 crore over 10 quarters. This represents a CAGR of 10.37% .

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Torrent Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
29 Oct 20243210.95
28 Oct 20243314.3
25 Oct 20243437.65
24 Oct 20243317.25
23 Oct 20243321.1
22 Oct 20243336.75
21 Oct 20243392.8
18 Oct 20243447.8
17 Oct 20243396.2
16 Oct 20243513.4

Historical Market Cap of Torrent Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Torrent Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Torrent Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Torrent Pharmaceuticals Ltd

No data available

* All values are in crore

Torrent Pharmaceuticals Ltd News Hub

News

Torrent Pharma Q2 PAT climbs 17% YoY to Rs 453 crore

Revenue from operations rose 8.60% year on year (YoY) to Rs 2,889 crore in the quarter end...

Read more

26 Oct 202414:13

News

Torrent Pharmaceuticals announces board meeting date

Torrent Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 25...

Read more

10 Oct 202417:21

News

Torrent Pharma's Madhya Pradesh facility concludes GMP inspection with 1 observation

The GMP inspection was conducted from 16 September to 20 September 2024. At the conclusion...

Read more

20 Sep 202414:40

News

Torrent Pharma hits life as Gujarat unit gets EIR from USFDA

Earlier on 12 June 2024, the pharmaceutical company informed that the US FDA had conducted...

Read more

30 Aug 202409:46

News

Torrent Pharmaceuticals announces change in senior management

Torrent Pharmaceuticals announced that Pranav Mehta has been elevated as Executive Directo...

Read more

13 Aug 202411:08

News

Torrent Pharma Q1 PAT climbs 21% YoY to Rs 457 crore

Revenue from operations rose 10.34% year on year (YoY) to Rs 2,859 crore in the quarter en...

Read more

24 Jul 202410:27

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

July 2024

Transcript

May 2024

Transcript

Feb 2024

Transcript

Aug 2023

Transcript

May 2023

Transcript

Sep 2022

PPT

May 2021

Transcript

Feb 2021

Transcript

Oct 2020

Transcript

July 2020

Transcript

May 2020

Transcript

FAQs for Quarterly Results of Torrent Pharmaceuticals Ltd

What key financial metrics are included in Torrent Pharmaceuticals Ltd's quarterly results?

Key financial metrics in Torrent Pharmaceuticals Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Torrent Pharmaceuticals Ltd announce its quarterly results?

Torrent Pharmaceuticals Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Torrent Pharmaceuticals Ltd's quarterly performance impact its stock price?

Torrent Pharmaceuticals Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Torrent Pharmaceuticals Ltd's quarterly results on dividends?

The impact of Torrent Pharmaceuticals Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Torrent Pharmaceuticals Ltd's quarterly results?

Yes, Torrent Pharmaceuticals Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*